| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 67014* | 2016 |
| 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice … PA Heidenreich, B Bozkurt, D Aguilar, LA Allen, JJ Byun, MM Colvin, ... Journal of the American College of Cardiology 79 (17), e263-e421, 2022 | 7156* | 2022 |
| 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on … Writing Committee Members, CM Otto, RA Nishimura, RO Bonow, ... Journal of the American College of Cardiology 77 (4), e25-e197, 2021 | 6566* | 2021 |
| 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology … SD Fihn, JM Gardin, J Abrams, K Berra, JC Blankenship, AP Dallas, ... Journal of the American College of Cardiology 60 (24), e44-e164, 2012 | 2452 | 2012 |
| Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes RR Holman, MA Bethel, RJ Mentz, VP Thompson, Y Lokhnygina, JB Buse, ... New England Journal of Medicine 377 (13), 1228-1239, 2017 | 2189 | 2017 |
| 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint … Writing Committee Members, M Gulati, PD Levy, D Mukherjee, ... Journal of the American College of Cardiology 78 (22), e187-e285, 2021 | 2022 | 2021 |
| Diuretic strategies in patients with acute decompensated heart failure GM Felker, KL Lee, DA Bull, MM Redfield, LW Stevenson, SR Goldsmith, ... New England Journal of Medicine 364 (9), 797-805, 2011 | 2007 | 2011 |
| Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction SD Solomon, JJV McMurray, B Claggett, RA de Boer, D DeMets, ... New England Journal of Medicine 387 (12), 1089-1098, 2022 | 2000 | 2022 |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1557 | 2018 |
| Effect of nesiritide in patients with acute decompensated heart failure CM O'Connor, RC Starling, AF Hernandez, PW Armstrong, K Dickstein, ... New England Journal of Medicine 365 (1), 32-43, 2011 | 1496 | 2011 |
| Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial MM Redfield, HH Chen, BA Borlaug, MJ Semigran, KL Lee, G Lewis, ... Jama 309 (12), 1268-1277, 2013 | 1382 | 2013 |
| Vericiguat in patients with heart failure and reduced ejection fraction PW Armstrong, B Pieske, KJ Anstrom, J Ezekowitz, AF Hernandez, ... New England Journal of Medicine 382 (20), 1883-1893, 2020 | 1259 | 2020 |
| Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure AF Hernandez, MA Greiner, GC Fonarow, BG Hammill, PA Heidenreich, ... Jama 303 (17), 1716-1722, 2010 | 1231 | 2010 |
| Ultrafiltration in decompensated heart failure with cardiorenal syndrome BA Bart, SR Goldsmith, KL Lee, MM Givertz, CM O'Connor, DA Bull, ... New England Journal of Medicine 367 (24), 2296-2304, 2012 | 1205 | 2012 |
| Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry SJ Greene, J Butler, NM Albert, AD DeVore, PP Sharma, CI Duffy, CL Hill, ... Journal of the American College of Cardiology 72 (4), 351-366, 2018 | 1169 | 2018 |
| Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes KS Shah, H Xu, RA Matsouaka, DL Bhatt, PA Heidenreich, AF Hernandez, ... Journal of the American College of Cardiology 70 (20), 2476-2486, 2017 | 1095 | 2017 |
| Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke JL Saver, GC Fonarow, EE Smith, MJ Reeves, MV Grau-Sepulveda, ... Jama 309 (23), 2480-2488, 2013 | 1071 | 2013 |
| Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes BA Steinberg, X Zhao, PA Heidenreich, ED Peterson, DL Bhatt, ... Circulation 126 (1), 65-75, 2012 | 913 | 2012 |
| 2017 comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure JA Ezekowitz, E O'Meara, MA McDonald, H Abrams, M Chan, ... Canadian Journal of Cardiology 33 (11), 1342-1433, 2017 | 863 | 2017 |
| Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times … GC Fonarow, EE Smith, JL Saver, MJ Reeves, DL Bhatt, ... Circulation 123 (7), 750-758, 2011 | 773 | 2011 |
Gregg C. FonarowUCLA Division of CardiologyZweryfikowany adres z mednet.ucla.edu
